Search research articles
Contact Us
Filters
Showing results (71-80 of 134) with videos related to
Page
of 14
Sort By:
Annals of the Rheumatic Diseases
|
September 21, 2017
The value of <sup>18</sup>F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study
Verena Schönau, Kristin Vogel, Matthias Englbrecht, et al.
Annals of the Rheumatic Diseases
|
July 24, 2010
Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade
Juergen Rech, Monika Ronneberger, Matthias Englbrecht, et al.
Seminars in Arthritis and Rheumatism
|
June 22, 2012
Premature osteoarthritis as presenting sign of type II collagenopathy: a case report and literature review
Emma Husar-Memmer, Arif Ekici, Ali Al Kaissi, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
May 24, 2015
How neutrophil extracellular traps orchestrate the local immune response in gout
Christian Maueröder, Deborah Kienhöfer, Jonas Hahn, et al.
The Journal of Rheumatology. Supplement
|
September 4, 2012
Measuring pain and efficacy of pain treatment in inflammatory arthritis: a systematic literature review
Matthias Englbrecht, Ingo H Tarner, Désirée M van der Heijde, et al.
The Journal of Rheumatology
|
February 17, 2010
Standardization of joint examination technique leads to a significant decrease in variability among different examiners
Mathias Grunke, Christian E Antoni, Arthur Kavanaugh, et al.
Rheumatology (Oxford, England)
|
July 8, 2022
Effective and safe treatment of anti-CD38 therapy in systemic lupus erythematosus-associated refractory cerebral vasculitis induces immune tolerance
Melek Yalcin Mutlu, Jochen Wacker, Koray Tascilar, et al.
Rheumatology (Oxford, England)
|
November 21, 2019
Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis
Martin Schäfer, Yvette Meißner, Jörn Kekow, et al.
Rheumatology (Oxford, England)
|
February 20, 2020
Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis
Martin Schäfer, Yvette Meißner, Jörn Kekow, et al.
The New England Journal of Medicine
|
August 4, 2021
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
Dimitrios Mougiakakos, Gerhard Krönke, Simon Völkl, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 134) with videos related to
Sort By:
Page
of 14
Annals of the Rheumatic Diseases
|
September 21, 2017
The value of <sup>18</sup>F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study
Verena Schönau, Kristin Vogel, Matthias Englbrecht, et al.
Annals of the Rheumatic Diseases
|
July 24, 2010
Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade
Juergen Rech, Monika Ronneberger, Matthias Englbrecht, et al.
Seminars in Arthritis and Rheumatism
|
June 22, 2012
Premature osteoarthritis as presenting sign of type II collagenopathy: a case report and literature review
Emma Husar-Memmer, Arif Ekici, Ali Al Kaissi, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
May 24, 2015
How neutrophil extracellular traps orchestrate the local immune response in gout
Christian Maueröder, Deborah Kienhöfer, Jonas Hahn, et al.
The Journal of Rheumatology. Supplement
|
September 4, 2012
Measuring pain and efficacy of pain treatment in inflammatory arthritis: a systematic literature review
Matthias Englbrecht, Ingo H Tarner, Désirée M van der Heijde, et al.
The Journal of Rheumatology
|
February 17, 2010
Standardization of joint examination technique leads to a significant decrease in variability among different examiners
Mathias Grunke, Christian E Antoni, Arthur Kavanaugh, et al.
Rheumatology (Oxford, England)
|
July 8, 2022
Effective and safe treatment of anti-CD38 therapy in systemic lupus erythematosus-associated refractory cerebral vasculitis induces immune tolerance
Melek Yalcin Mutlu, Jochen Wacker, Koray Tascilar, et al.
Rheumatology (Oxford, England)
|
November 21, 2019
Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis
Martin Schäfer, Yvette Meißner, Jörn Kekow, et al.
Rheumatology (Oxford, England)
|
February 20, 2020
Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis
Martin Schäfer, Yvette Meißner, Jörn Kekow, et al.
The New England Journal of Medicine
|
August 4, 2021
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
Dimitrios Mougiakakos, Gerhard Krönke, Simon Völkl, et al.
Page
of 14